drugset / Trial / NCT02354027

The Drug-drug Interaction of SHR3824 and Metformin

NCT02354027

Phase 1 Completed 12 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the potential interaction between multiple oral doses of SHR3824 and a single oral dose of metformin in healthy adult volunteers.

Timeline

Start
2014-09
Primary completion
2014-11
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Henagliflozin Small molecule 25 mg Oral
Subject Metformin Small molecule 1000 mg Oral